Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-073613
Filing Date
2025-05-16
Accepted
2025-05-16 16:30:25
Documents
1
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10781
  Complete submission text file 0000950170-25-073613.txt   12159
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Issuer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Porter James Richard (Reporting) CIK: 0001862900 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40671 | Film No.: 25959768